TipRanks
Aoyuan Healthy Life Group Co. Ltd. (HK:3662)
:3662
Hong Kong Market
Want to see HK:3662 full AI Analyst Report?

Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

1 Followers

Top Page

HK:3662

Aoyuan Healthy Life Group Co. Ltd.

(3662)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - Gpt-5.6Sol)
Rating:59Neutral
Price Target:
HK$0.43
â–¼(-1.36% Downside)
Action:Reiterated
Date:09/23/26
The score is driven primarily by mixed financial performance (weakening revenue/margins and softer 2025 cash flow despite very low leverage), with valuation providing meaningful support (low P/E and a dividend) and technical indicators remaining broadly neutral to mildly positive.
Positive Factors
Conservative Balance Sheet
The sharp reduction in leverage gives Aoyuan Healthy Life greater financial resilience and lowers exposure to interest and refinancing pressure. A sizable equity base also provides a stronger cushion for managing operational volatility and funding essential property-service activities.
Negative Factors
Prolonged Revenue Decline
A multiyear revenue decline signals sustained pressure on the company’s operating scale rather than a single-period fluctuation. If this trend persists, it can reduce the contribution from managed services, weaken operating leverage, and make a durable recovery in earnings more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
The sharp reduction in leverage gives Aoyuan Healthy Life greater financial resilience and lowers exposure to interest and refinancing pressure. A sizable equity base also provides a stronger cushion for managing operational volatility and funding essential property-service activities.
Read all positive factors

Aoyuan Healthy Life Group Co. Ltd. (3662) vs. iShares MSCI Hong Kong ETF (EWH)

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company Description
Operating within the People's Republic of China, Aoyuan Healthy Life Group Company Limited, through its various subsidiaries, specializes in delivering comprehensive property management and commercial operations solutions. Its property management ...
How the Company Makes Money
The company primarily makes money by charging recurring fees for property management services, typically collected from property owners, residents, and/or property developers for day-to-day estate operations (e.g., security, cleaning, maintenance ...

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary
Mixed fundamentals: a materially weaker income trend (multi-year revenue decline and margin compression) and inconsistent cash generation with a sharp 2025 pullback weigh heavily, partially offset by a much cleaner, low-leverage balance sheet that reduces financial risk.
Income Statement
44
Neutral
Balance Sheet
72
Positive
Cash Flow
36
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.19B1.22B1.36B1.56B1.63B1.94B
Gross Profit312.59M312.54M385.04M399.62M397.21M469.57M
EBITDA117.29M121.50M159.44M202.52M245.27M-108.96M
Net Income47.44M51.57M96.22M157.14M160.41M-190.94M
Balance Sheet
Total Assets2.10B2.23B2.36B2.28B2.22B2.29B
Cash, Cash Equivalents and Short-Term Investments908.44M1.01B1.05B984.50M857.81M1.21B
Total Debt57.90M65.29M81.69M114.94M158.29M412.59M
Total Liabilities894.58M997.36M1.11B1.13B1.23B1.50B
Stockholders Equity1.19B1.21B1.20B1.10B931.48M747.32M
Cash Flow
Free Cash Flow35.00M31.62M107.61M93.52M-108.95M-98.54M
Operating Cash Flow40.93M37.98M140.33M106.01M-105.68M-86.34M
Investing Cash Flow14.83M-1.37M-30.53M67.93M-50.65M31.09M
Financing Cash Flow-78.63M-69.06M-51.28M-48.34M-272.10M-245.32M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.44
Price Trends
50DMA
0.35
Positive
100DMA
0.34
Positive
200DMA
0.35
Positive
Market Momentum
MACD
0.01
Negative
RSI
65.75
Neutral
STOCH
88.14
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Positive. The current price of 0.44 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.35, and above the 200-day MA of 0.35, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 65.75 is Neutral, neither overbought nor oversold. The STOCH value of 88.14 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$171.98M1.5115.16%13.17%4.17%10.89%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
65
Neutral
HK$208.38M49.0030.35%114.57%0.04%-95.28%
63
Neutral
HK$483.43M-5.05-10.95%8.95%-0.09%-101.15%
59
Neutral
HK$294.13M5.423.96%2.00%-2.92%24.02%
44
Neutral
HK$141.10M-2.04-6.74%1.45%-7.66%-3032.69%
44
Neutral
HK$185.41M-0.66-52.88%2.15%1.89%-805.91%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3662
Aoyuan Healthy Life Group Co. Ltd.
0.42
-0.03
-7.57%
HK:1153
Jiayuan Services Holdings Limited
0.31
-0.19
-38.00%
HK:1895
Xinyuan Property Management Service (Cayman) Ltd.
0.29
-0.23
-44.23%
HK:1971
Redsun Services Group Ltd
0.33
-0.02
-5.71%
HK:2107
First Service Holding Limited
0.38
0.13
49.02%
HK:2215
Dexin Services Group Ltd.
0.20
-0.32
-61.73%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Starjoy Wellness and Travel Posts Higher Net Profit But Lower Core Earnings in Interim Results
Aug 27, 2026
Starjoy Wellness and Travel Company Limited reported interim results for the six months ended 30 June 2026 showing revenue of RMB579.3 million, a year-on-year decline of about 5.2%, while gross profit stayed broadly flat at RMB168.3 million. The g...
Starjoy Wellness and Travel Declares Interim Dividend for First Half of 2026
Aug 27, 2026
Starjoy Wellness and Travel Company Limited has declared an interim ordinary cash dividend of RMB 0.0072 per share for the six months ended 30 June 2026, equivalent to HKD 0.0083 per share based on an exchange rate of RMB 1 to HKD 1.1556. The divi...
Starjoy Wellness and Travel Sets Board Meeting to Approve 2026 Interim Results
Aug 17, 2026
Starjoy Wellness and Travel Company Limited has scheduled a board meeting for 27 August 2026 to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the declaration of an interim ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 23, 2026